2017
DOI: 10.1073/pnas.1707544114
|View full text |Cite
|
Sign up to set email alerts
|

M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer’s disease genes and improving memory

Abstract: SignificanceHundreds of failed clinical trials with Alzheimer’s disease (AD) patients over the last fifteen years demonstrate that the one-target–one-disease approach is not effective in AD. In silico, structure-based, multitarget drug design approaches to treat multifactorial diseases have not been successful in the context of AD either. Here, we show that M344, an inhibitor of class I and IIB histone deacetylases, affects multiple AD-related genes, including those related to both early- and late-onset AD. We… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
45
0
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 57 publications
(48 citation statements)
references
References 87 publications
2
45
0
1
Order By: Relevance
“…This information showed that anti-neuroinflammation was an important mechanism underlying the prevention of BHB to postsepsis cognitive impairment. Previous studies showed that BHB was an endogenous histone deacetylase inhibitor [18], and sepsis induced obvious changes of histone deacetylases [25][26][27]. Thus, histone deacetylases were the possible downstream molecules of HCA2 and MCT2.…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…This information showed that anti-neuroinflammation was an important mechanism underlying the prevention of BHB to postsepsis cognitive impairment. Previous studies showed that BHB was an endogenous histone deacetylase inhibitor [18], and sepsis induced obvious changes of histone deacetylases [25][26][27]. Thus, histone deacetylases were the possible downstream molecules of HCA2 and MCT2.…”
Section: Discussionmentioning
confidence: 97%
“…A novel object recognition test (NOR) was conducted during the 14 th and 15 th days after CLP in a 30×30×20-cm field following the reported protocol [17,18]. The test consisted of two phases: a familiarization and a test phase.…”
Section: Novel Object Recognitionmentioning
confidence: 99%
“…In our experiments, we have detected the expression of tagged vsps in cell lines treated with splitomicin more often than treated with TSA, Apicidin, M344, and NaPB, when compared to untreated controls. Apicidin [10], TSA [11], NaPB [12], and M344 [13] are known to inhibit NAD + independent histone deacetylases that belong to class I HDACs. A homologue of class I HDAC has been identified in the Giardia genome database and previous reports have indicated that this enzyme can be inhibited by TSA, Apicidin, and NaPB [6,8].…”
Section: Discussionmentioning
confidence: 99%
“…Another important and unique feature of the presented protocol is its full compatibility with downstream western blot analysis tools and others if so desired. Histone proteins are detected at ~15 kDa 13,22,23 and, similarly to other small molecular weight proteins, have been proven challenging to detect by standard immunoblotting techniques. The use of a high-performance and high-throughput transfer system in combination with optimal resolution protein gels allows for the maintenance of protein native confirmation (in the absence of SDS) and activity in the absence of SDS and high transfer efficiency of the low molecular weight histone proteins, thus assuring a reliable histone PTM quantification.…”
Section: Discussionmentioning
confidence: 99%